121 – 130 of 217
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Antibodies against Kaposi sarcoma-associated herpes virus (KSHV) complement control protein (KCP) in infected individuals
(
- Contribution to journal › Article
-
Mark
HPV type-specific risks of high-grade CIN during 4 years of follow-up: A population-based prospective study
(
- Contribution to journal › Article
-
Mark
Population-based study of screening test performance indices of three human papillomavirus DNA tests
(
- Contribution to journal › Article
-
Mark
Cervical cancer and hormonal contraceptives: Collaborative reanalysis of individual data for 16 573 women with cervical cancer and 35 509 women without cervical cancer from 24 epidemiological studies
(
- Contribution to journal › Article
-
Mark
Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials
(
- Contribution to journal › Article
-
Mark
Review of current knowledge on HPV vaccination: An Appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening.
(
- Contribution to journal › Scientific review
-
Mark
No excess risk for colorectal cancer among subjects seropositive for the JC polyomavirus.
(
- Contribution to journal › Article
-
Mark
Activation of maternal Epstein-Barr virus infection and risk of acute leukemia in the offspring
(
- Contribution to journal › Article
-
Mark
Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland
(
- Contribution to journal › Article
-
Mark
Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions
(
- Contribution to journal › Article